Cardiometabolic Risk of Obese Subjects: Cross-sectional Study
Recruiting now
Conditions studied: Obesity and Obesity-related Medical Conditions, Cardiovascular Risk, Genetics
In brief
experimental study with analysis on tissues. This study aims to study cardiometabolic risk from a genetic, clinical, instrumental and laboratory point of view in a population of subjects with obesity.
Key facts
- Study ID
- NCT06714058
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- People needed
- 240
- Starts
- 2024-11-30
- Expected to finish
- 2025-04-30
- Last updated by the study team
- 2024-12-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- • Age > 18 years
- BMI > 30 Kg/m2
- In primary prevention for cardiovascular disease
- Ability to communicate, make themselves understood and adhere to study-specific procedures
- Willingness to participate in the study and obtain informed consent
You may not qualify if…
- Patients already enrolled by the Research Units involved in the enrolment
- Glycated hemoglobin level > 55 mmol/L
- Patients suffering from obesity secondary to endocrinological diseases or iatrogenic causes
- Patients with heterozygous Familial Hypercholesterolemia (Dutch Lipid Score - DLS>8)
- Patients suffering from hypercholesterolemia secondary to lipid or iatrogenic extra-metabolic pathologies
- Patients suffering from systemic inflammatory or oncological diseases
- Patients on active treatment with GLP-1 analogues
- Pregnancy and breastfeeding
- Any medical or surgical condition that makes the patient's adherence to the study protocol complex or inconsistent.
Where it is running
- Maria Letizia Petroni — Bologna, BO, Italy (enrolling)
- Azienda Ospedaliero-Universitaria "Renato Dulbecco" di Catanzaro — Catanzaro, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.